The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation

Arthritis Research and Therapy

Volumn 12, Issue 4, 2010, Pages

  Valenti, Maria Teresa ^a   Giannini, Sandro ^b   Donatelli, Luca ^a   Zanatta, Mirko ^a   Bertoldo, Francesco ^a   Sella, Stefania ^b   Vilei, Maria Teresa ^b   Ossi, Elena ^b   Realdi, Giuseppe ^b   Lo Cascio, Vincenzo ^a   Dalle Carbonare, Luca ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CYCLOOXYGENASE 2; DEXAMETHASONE; GLUCOCORTICOID; METHYLPREDNISOLONE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; RISEDRONIC ACID; BONE DENSITY CONSERVATION AGENT; DRUG DERIVATIVE; ETIDRONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE TURNOVER; CELL LINEAGE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOCYTE; OSTEOPOROSIS; PROTEIN EXPRESSION; RAT; ANIMAL; BONE DEVELOPMENT; CELL CULTURE; CELL LINE; CELL SURVIVAL; CYTOLOGY; ENZYMOLOGY; GENETICS; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; APOPTOSIS; BONE DENSITY CONSERVATION AGENTS; BONE MARROW CELLS; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; CYCLOOXYGENASE 2; ETIDRONIC ACID; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; OSTEOCYTES; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 77955791975     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3122     Document Type: Article

References (50)

1. Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 2007, 1117:209-257. 10.1196/annals.1402.089, 18056045.
2. Viereck V, Emons G, Lauck V, Frosch KH, Blaschke S, Gründker C, Hofbauer LC. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Comm 2002, 291:680-686. 10.1006/bbrc.2002.6510, 11855844.
3. Follet H, Li J, Phipps RJ, Hui S, Condon K, Burr DB. Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading. Bone 2007, 40:1172-1177. 10.1016/j.bone.2006.12.052, 17240209.
4. Storm T, Steinichw T, Thamsborg G, Melsen F. Changes in bone histomorphometry after long-term treatment with intermittent cyclic etidronate for postmenopausal osteoporosis. J Bone Miner Res 1993, 8:199-208. 10.1002/jbmr.5650080211, 8442438.
5. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA. Bisphosphonate action. Alendronate localization in rat bone and effects on osteclast ultrastructure. J Clin Invest 1991, 88:2095-2105. 10.1172/JCI115539, 295810, 1661297.
6. Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA, . Alendronate Phase III Osteoporosis Treatment Study Group Ten years experience with alendronate for osteoporosis in postmenopausal women. N Eng J Med 2004, 350:1189-1199. 10.1056/NEJMoa030897, 15028823, Alendronate Phase III Osteoporosis Treatment Study Group.
7. Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, Spelsberg TC. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 2000, 60:6001-6007.
8. Ebert R, Zeck S, Krug R, Meissner-Weigl J, Schneider D, Seefried L, Eulert J, Jakob F. Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation. Bone 2009, 44:858-864. 10.1016/j.bone.2009.01.009, 19442618.
9. Giuliani N, Pedrazzoni M, Passeri G, Girasole G. Bisphosphonates inhibit IL-6 production by human osteoblastlike cells. Scand J Rheum 1998, 27:38-41. 10.1080/030097498441155, 9506876.
10. Giuliani N, Pedrazzoni M, Negri G, Passeri G, Impicciatore M, Girasole G. Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 1998, 22:455-461. 10.1016/S8756-3282(98)00033-7, 9600778.
11. Von Knoch F, Jaquiery C, Kowalsky M, Schaeren S, Alabre C, Martin I, Rubash HE, Shanbhag AS. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 2005, 26:6941-6949. 10.1016/j.biomaterials.2005.04.059, 16009417.
12. Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 1999, 104:1363-1374. 10.1172/JCI6800, 409837, 10562298.
13. Marotti C, Palumbo G. The mechanism of transduction of mechanical strains into biological signals at the bone cellular level. Eur J Histochem 2007, 51(Suppl 1):15-19.
14. Burger EH, Klein-Nulend J, van der Plas A, Nijweide PJ. Function of osteocytes in bone--their role in mechanotransduction. J Nutr 1995, 125:2020S-2023S.
15. Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995, 54:801-806. 10.1136/ard.54.10.801, 1010013, 7492217.
16. Dalle Carbonare L, Bertoldo F, Valenti MT, Zordan S, Sella S, Fassina A, Turco G, Realdi G, Lo Cascio V, Giannini S. Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. J Endocrinol Invest 2007, 30:739-746.
17. Mundy G, Garret R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science 1999, 286:1946-1949. 10.1126/science.286.5446.1946, 10583956.
18. Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 2004, 25:4105-4115. 10.1016/j.biomaterials.2003.11.024, 15046901.
19. Koshishara Y, Kawamura M. Prostaglandins D2 stimulates calcification of human osteoblast cells. Biochem Biophys Res Comm 1989, 159:1206-1212. 10.1016/0006-291X(89)92238-9, 2930558.
20. Tasaki Y, Takamori R, Koshihara Y. Prostaglandins D2 metabolite stimulates collagen synthesis by human osteoblasts during calcification. Prostaglandins 1991, 41:303-313. 10.1016/0090-6980(91)90001-V, 1871375.
21. Gronowicz GA, Fall PM, Raisz LG. Prostaglandin E2 stimulates preosteoblast replication: an autoradiographic study in cultured fetal rat calvariae. Exp Cell Res 1994, 212:314-320. 10.1006/excr.1994.1149, 8187824.
22. Scutt A, Bertram P. Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from non-adherent to adherent osteoblast precursors. J Bone Miner Res 1995, 10:474-487. 10.1002/jbmr.5650100320, 7785470.
23. Scutt A, Bertram P, Brautigam M. The role of glucocorticoid and prostaglandins E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: positive and negative effects. Calcif Tissue Int 1996, 59:154-162. 10.1007/s002239900102, 8694891.
24. Smith WL, Song I. The enzymology of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat 2002, 68-69:115-128. 10.1016/S0090-6980(02)00025-4, 12432913.
25. Herschman HR, Xie W, Reddy S. Inflammation, reproduction, cancer and all that. The regulation and role of the inducible prostaglandin synthase. BioEssays 1995, 17:1031-1037. 10.1002/bies.950171207, 8634064.
26. Botting R, Ayoub SS. COX-3 and the mechanism of action of paracetamol/acetaminophen. Prostag Leukot Essent. Prostaglandins Leukot Essent Fatty Acids 2005, 72:85-87. 10.1016/j.plefa.2004.10.005, 15626590.
27. Kis B, Snipes JA, Busija DW. Acetaminophen and the cycloxigenase-3 puzzle: sorting out fact, fictions and uncertainties. J Pharmacol Exp Ther 2005, 315:1-7. 10.1124/jpet.105.085431, 15879007.
28. Li J, Burr DB, Turner CH. Suppression of prostaglandins synthesis with NS-398 has different effects on endocortical and periostal bone formation induced by mechanical loading. Calcif Tissue Int 2002, 70:320-329. 10.1007/s00223-001-1025-y, 12004337.
29. Simon AM, Manigrasso MB, O'Connor JP. Cyclooxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002, 17:963-976. 10.1359/jbmr.2002.17.6.963, 12054171.
30. Choudhary S, Wadhawa S, Raisz LG, Alander C, Pilbeam CC. Extracellular calcium is a potent inducer of cyclooxygenase 2 in murine osteoblasts through an ERK signalling pathway. J Bone Miner Res 2003, 18:1813-1824. 10.1359/jbmr.2003.18.10.1813, 14584892.
31. Choudhary S, Halbout P, Alander C, Raisz L, Pilbeam C. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins. J Bone Miner Res 2007, 22:1002-1010. 10.1359/jbmr.070321, 17371157.
32. Pilbeam C, Fall PM, Alander CB, Raisz LG. Differential effects of non-steroidal anti-inflammatory drugs on constitutive and inducible prostaglandin G/H synthase in cultured bone cells. J Bone Miner Res 1997, 12:1198-203. 10.1359/jbmr.1997.12.8.1198, 9258749.
33. Kimmel DB. Quantitative histologic changes in the proximal tibial growth cartilage of aged female rats. Cells Materials 1991, (Suppl 1):11-18.
34. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res 1987, 2:595-610. 10.1002/jbmr.5650020617, 3455637.
35. Fortier C, Barbeau J, Deslauriers N. Mast cells in the murine oral mucosa are of the connective tissue-type. Reg Immunol 1990, 3:35-41.
36. Kato Y, Windle JJ, Koop BA, Mundy GR, Bonewald LF. Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res 1997, 12:2014-2023. 10.1359/jbmr.1997.12.12.2014, 9421234.
37. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996, 6:986-994. 10.1101/gr.6.10.986, 8908518.
38. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW, Dequeker J, Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995, 333:1437-1443. 10.1056/NEJM199511303332201, 7477143.
39. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996, 348:1535-1541. 10.1016/S0140-6736(96)07088-2, 8950879.
40. Mortensen L, Charles P, Bekker PJ, Digennaro J, Johnston CC. Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. J Clin Endocrinol Metab 1998, 83:396-402. 10.1210/jc.83.2.396, 9467547.
41. Sahni M, Guenther HL, Fleisch H, Collin P, Martin TJ. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 1993, 91:2004-2011. 10.1172/JCI116422, 288198, 8486770.
42. Flanagan AM, Chambers TJ. Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2. Endocrinology 1992, 130:443-448. 10.1210/en.130.1.443, 1309342.
43. Ueda K, Saito A, Nakano H, Aoshima M, Yokota M, Muraoka R, Iwaya T. Cortical hyperostosis following long-term administration of prostaglandins E1 in infants with cyanotic heart disease. J Pediatr 1980, 97:834-836. 10.1016/S0022-3476(80)80282-4, 7000997.
44. Norrdin RW, Shih MS. Systemic effects of prostaglandin E2 on vertebral trabecular remodelling in beagles used in a healing study. Calcif Tissue Int 1988, 42:363-368. 10.1007/BF02556354, 3135105.
45. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineageand is critically involved in bone repair. J Clin Invest 2002, 109:1405-1415. 151001, 12045254.
46. Naik AA, Xie C, Zuscik MJ, Kingsley P, Schwarz EM, Awad H, Guldberg R, Drissi H, Puzas JE, Boyce B, Zhang X, O'Keefe RJ. Reduced COX-2 expression in aged mice s associated with impaired fracture healing. J Bone Miner Res 2009, 24:251-264. 10.1359/jbmr.081002, 18847332.
47. Trifan OC, Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med 2003, 7:207-222. 10.1111/j.1582-4934.2003.tb00222.x, 14594546.
48. Lauc G, Heffer-Lauc M. Shedding and uptake of gangliosides and glycosylphosphatidylinositol-anchored proteins. Biochim Biophys Acta 2006, 1760:584-602.
49. Fishman WH. Alkaline phosphatase isozymes: recent progress. Clin Biochem 1990, 23:99-104. 10.1016/0009-9120(90)80019-F, 2197029.
50. Liu JF, Zhu GJ, Jamieson GG, Wu TC, Zhu TN, Shan BE, Drew PA. NS-398 induces apoptosis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygenase-2. Cancer Invest 2009, 27:17-23. 10.1080/07357900801992913, 19160097.